InnovAge Holding [INNV] vs Pediatrix Medical [MD] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: InnovAge Holding Corp. wins in 4 metrics, Pediatrix Medical Group, Inc. wins in 16 metrics, with 0 ties. Pediatrix Medical Group, Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | InnovAge Holding Corp. | Pediatrix Medical Group, Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 152.00 | 11.88 | Pediatrix Medical Group, Inc. |
| Price-to-Book Ratio | 4.02 | 2.16 | Pediatrix Medical Group, Inc. |
| Debt-to-Equity Ratio | 33.02 | 73.29 | InnovAge Holding Corp. |
| PEG Ratio | -0.84 | 9.90 | Pediatrix Medical Group, Inc. |
| EV/EBITDA | 23.81 | 7.92 | Pediatrix Medical Group, Inc. |
| Profit Margin (TTM) | 0.71% | 8.64% | Pediatrix Medical Group, Inc. |
| Operating Margin (TTM) | 5.53% | 11.07% | Pediatrix Medical Group, Inc. |
| EBITDA Margin (TTM) | 5.53% | 11.07% | Pediatrix Medical Group, Inc. |
| Return on Equity | 1.18% | 20.28% | Pediatrix Medical Group, Inc. |
| Return on Assets (TTM) | 2.92% | 6.57% | Pediatrix Medical Group, Inc. |
| Free Cash Flow (TTM) | $26.60M | $252.63M | Pediatrix Medical Group, Inc. |
| 1-Year Return | 85.57% | 52.23% | InnovAge Holding Corp. |
| Price-to-Sales Ratio (TTM) | 1.13 | 1.00 | Pediatrix Medical Group, Inc. |
| Enterprise Value | $1.03B | $2.00B | Pediatrix Medical Group, Inc. |
| EV/Revenue Ratio | 1.13 | 1.05 | Pediatrix Medical Group, Inc. |
| Gross Profit Margin (TTM) | 22.04% | 25.51% | Pediatrix Medical Group, Inc. |
| Revenue per Share (TTM) | $7 | $23 | Pediatrix Medical Group, Inc. |
| Earnings per Share (Diluted) | $0.05 | $1.94 | Pediatrix Medical Group, Inc. |
| Beta (Stock Volatility) | 0.50 | 0.72 | InnovAge Holding Corp. |
| Short % of Float | 2.67% | 6.00% | InnovAge Holding Corp. |
InnovAge Holding Corp. vs Pediatrix Medical Group, Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| InnovAge Holding Corp. | -1.94% | -4.71% | -13.34% | -25.40% | 39.37% | 36.42% |
| Pediatrix Medical Group, Inc. | 0.37% | 0.88% | -2.54% | 10.64% | -6.23% | 2.58% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| InnovAge Holding Corp. | 85.57% | 0.93% | -62.83% | -68.48% | -68.48% | -68.48% |
| Pediatrix Medical Group, Inc. | 52.23% | 53.97% | -32.60% | -68.09% | -39.53% | -4.27% |
Performance & Financial Health Analysis: InnovAge Holding Corp. vs Pediatrix Medical Group, Inc.
| Metric | INNV | MD |
|---|---|---|
| Market Information | ||
| Market Cap | $1.05B | $1.91B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 215,510 | 510,889 |
| 90 Day Avg. Volume | 278,257 | 755,756 |
| Last Close | $7.08 | $21.84 |
| 52 Week Range | $3.13 - $10.69 | $11.84 - $24.99 |
| % from 52W High | -33.77% | -12.61% |
| All-Time High | $27.18 (Mar 22, 2021) | $86.09 (Aug 17, 2015) |
| % from All-Time High | -73.95% | -74.63% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | -0.02% |
| Quarterly Earnings Growth | 0.15% | 0.11% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.09% |
| Operating Margin (TTM) | 0.06% | 0.11% |
| Return on Equity (TTM) | 0.01% | 0.20% |
| Debt to Equity (MRQ) | 33.02 | 73.29 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.89 | $10.68 |
| Cash per Share (MRQ) | $0.93 | $6.16 |
| Operating Cash Flow (TTM) | $58.91M | $271.09M |
| Levered Free Cash Flow (TTM) | $54.64M | $190.33M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: InnovAge Holding Corp. vs Pediatrix Medical Group, Inc.
| Metric | INNV (Apr 24, 2026) | MD (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 152.00 | 11.88 |
| Forward P/E | 22.35 | 9.90 |
| PEG Ratio | -0.84 | 9.90 |
| Price to Sales (TTM) | 1.13 | 1.00 |
| Price to Book (MRQ) | 4.02 | 2.16 |
| Market Capitalization | ||
| Market Capitalization | $1.05B | $1.91B |
| Enterprise Value | $1.03B | $2.00B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.13 | 1.05 |
| Enterprise to EBITDA | 23.81 | 7.92 |
| Risk & Other Metrics | ||
| Beta | 0.50 | 0.72 |
| Book Value per Share (MRQ) | $1.89 | $10.68 |
Financial Statements Comparison: InnovAge Holding Corp. vs Pediatrix Medical Group, Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | INNV (2025) | MD (2025) |
|---|---|---|
| Revenue/Sales | 853.70M | 1.91B |
| Cost of Goods Sold | 700.06M | 1.42B |
| COGS % of Revenue | 82.0% | 74.2% |
| Gross Profit | 153.64M | 493.70M |
| Gross Margin | 18.0% | 25.8% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | -16.15M | 231.09M |
| Operating Margin | -1.9% | 12.1% |
| EBITDA | 3.71M | 256.55M |
| EBITDA Margin | 0.4% | 13.4% |
| Pre-Tax Income | -34.03M | 216.43M |
| Pre-Tax Income % of Revenue | -4.0% | 11.3% |
| Income Tax | 1.32M | 51.04M |
| Income Tax % of Revenue | 0.2% | 2.7% |
| Net Income (Profit) | -35.34M | 165.39M |
| Profit Margin | -4.1% | 8.6% |
Balance Sheet & Liquidity Metrics
| Metric | INNV (2025) | MD (2025) |
|---|---|---|
| Cash & Equivalents | 64.13M | 375.24M |
| Total Current Assets | 176.11M | 763.51M |
| Total Current Assets % of Revenue | 20.6% | 39.9% |
| Total Current Liabilities | 164.81M | 458.91M |
| Total Current Liabilities % of Revenue | 19.3% | 24.0% |
| Long-Term Debt | 88.92M | 596.22M |
| Long-Term Debt % of Revenue | 10.4% | 31.2% |
| Total Shareholders Equity | 262.91M | 865.85M |
| Retained Earnings | -101.05M | -83.15M |
| Retained Earnings % of Revenue | -11.8% | -4.3% |
| Property, Plant & Equipment | 26.90M | 195.53M |
Cash Flow Statement Comparison
| Metric | INNV (2025) | MD (2025) |
|---|---|---|
| Operating Cash Flow | 28.10M | 270.23M |
| Operating Cash Flow % of Revenue | 3.3% | 14.1% |
| Capital Expenditures | -6.26M | -18.46M |
| Free Cash Flow | 26.60M | 252.63M |
| FCF Margin | 3.1% | 13.2% |
| Debt Repayment | -9.91M | -20.75M |
| Common Stock Repurchase | -7.32M | -86.68M |
Short Interest & Institutional Ownership Analysis
| Metric | INNV | MD |
|---|---|---|
| Shares Short | 572,966 | 3.53M |
| Short Ratio | 1.59 | 3.77 |
| Short % of Float | 2.67% | 6.00% |
| Shares Outstanding | 135.70M | 82.98M |
| Float Shares | 21.46M | 79.95M |
| % Held by Insiders | 84.26% | 2.31% |
| % Held by Institutions | 13.00% | 106.63% |
| % Held by Public | 2.74% | -8.94% |
Dividend Analysis & Yield Comparison: InnovAge Holding Corp. vs Pediatrix Medical Group, Inc.
| Metric | INNV | MD |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |